{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:50:01Z","timestamp":1793418601165,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00296-022-05113-4","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T02:02:16Z","timestamp":1653530536000},"page":"1589-1596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of TNF-\u03b1 expression in unstable atherosclerotic plaques, serum IL-6 and TNF-\u03b1 levels in patients with acute coronary syndrome and rheumatoid arthritis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-5520","authenticated-orcid":false,"given":"Velichka","family":"Popova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-3846","authenticated-orcid":false,"given":"Mariela","family":"Geneva-Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-117X","authenticated-orcid":false,"given":"Krasimir","family":"Kraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8857-0574","authenticated-orcid":false,"given":"Anastas","family":"Batalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"5113_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1570161107913308522","volume":"4","author":"A Yuri Gasparyan","year":"2010","unstructured":"Yuri Gasparyan A, Stavropoulos-Kalinoglou A, P Mikhailidis D et al (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 4:437\u2013449. https:\/\/doi.org\/10.2174\/1570161107913308522","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"5113_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13075-019-1975-y","volume":"21","author":"P Ruscitti","year":"2019","unstructured":"Ruscitti P, Cipriani P, Liakouli V et al (2019) Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study. Arthritis Res Ther 21(1):204. https:\/\/doi.org\/10.1186\/s13075-019-1975-y","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5113_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00296-016-3638-5","volume":"37","author":"J Hoek","year":"2017","unstructured":"Hoek J, Boshuizen HC, Roorda LD et al (2017) Mortality in patients with rheumatoid arthritis: a. Rheumatol Int 37(4):487\u2013493. https:\/\/doi.org\/10.1007\/s00296-016-3638-5","journal-title":"Rheumatol Int"},{"key":"5113_CR4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M et al (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71:1524\u20131529. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200726","journal-title":"Ann Rheum Dis"},{"key":"5113_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.15420\/ecr.2020.44","volume":"16","author":"AM Kerola","year":"2021","unstructured":"Kerola AM, Rollefstad S, Semb AG (2021) Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment. Eur Cardiol Rev 16:e18. https:\/\/doi.org\/10.15420\/ecr.2020.44","journal-title":"Eur Cardiol Rev"},{"key":"5113_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/acr.22166","volume":"66","author":"A Bili","year":"2014","unstructured":"Bili A, Tang X, Pranesh S et al (2014) Tumor necrosis factor \u03b1 inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis. Arthritis Care Res 66:355\u2013363. https:\/\/doi.org\/10.1002\/acr.22166","journal-title":"Arthritis Care Res"},{"key":"5113_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/annrheumdis-2018-eular.1810","volume":"77","author":"R Westhovens","year":"2018","unstructured":"Westhovens R, Yoo D, Jaworski J et al (2018) THU0191 novel formulation of ct-p13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase I\/III randomised controlled trial. Ann Rheum Dis 77:315. https:\/\/doi.org\/10.1136\/annrheumdis-2018-eular.1810","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"5113_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/annrheumdis-2019-eular.1094","volume":"78","author":"D Yoo","year":"2019","unstructured":"Yoo D, Jaworski J, Matyska-Piekarska E et al (2019) FRI0128 A novel formulation of CT-P13 (infliximab biosimilar) for subcutaneous administration: 1-year results from a part 1 of phase I\/III randomized controlled trial in patients. Ann Rheum Dis 78(Suppl 2):733. https:\/\/doi.org\/10.1136\/annrheumdis-2019-eular.1094","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5113_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","volume":"65","author":"P Barath","year":"1990","unstructured":"Barath P, Fishbein C, Cao J et al (1990) Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65(5):297\u2013302. https:\/\/doi.org\/10.1016\/0002-9149(90)90291-8","journal-title":"Am J Cardiol"},{"issue":"8","key":"5113_CR10","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/ATVBAHA.116.307736","volume":"36","author":"L Zhu","year":"2016","unstructured":"Zhu L, Giunzioni I, Tavori H et al (2016) Antiatherogenic effects of tumor necrosis factor-inhibition loss of macrophage low-density lipoprotein receptor related protein 1 confers. Arterioscler Thromb Vasc Biol 36(8):1483\u20131495. https:\/\/doi.org\/10.1161\/ATVBAHA.116.307736","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5113_CR11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1161\/01.cir.101.18.2149","volume":"101","author":"P Ridker","year":"2000","unstructured":"Ridker P, Rifai N, Pfeffer M et al (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149\u20132153. https:\/\/doi.org\/10.1161\/01.cir.101.18.2149","journal-title":"Circulation"},{"issue":"8","key":"5113_CR12","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1136\/annrheumdis-2015-208720","volume":"75","author":"AY Gasparyan","year":"2016","unstructured":"Gasparyan AY, Kitas GD (2016) Platelets in rheumatoid arthritis: exploring the anti-inflammatory and antithrombotic potential of TNF inhibitors. Ann Rheum Dis 75(8):1426\u20131427. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208720","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5113_CR13","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"5113_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/157340308785160570","volume":"4","author":"T Hou","year":"2008","unstructured":"Hou T, Tieu BC, Ray S et al (2008) Roles of IL-6-gp130 signaling in vascular inflammation. Curr Cardiol Rev 4(3):179\u2013192. https:\/\/doi.org\/10.2174\/157340308785160570","journal-title":"Curr Cardiol Rev"},{"key":"5113_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1055\/s-0038-1650653","volume":"76","author":"J Stouthard","year":"1996","unstructured":"Stouthard J, Levi M, Hack C et al (1996) Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 76:738\u2013742","journal-title":"Thromb Haemost"},{"issue":"6","key":"5113_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/01.cir.92.6.1487","volume":"92","author":"G Torre-Amione","year":"1995","unstructured":"Torre-Amione G, Kapadia S, Lee J et al (1995) Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92(6):1487\u20131493. https:\/\/doi.org\/10.1161\/01.cir.92.6.1487","journal-title":"Circulation"},{"issue":"2","key":"5113_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ehj.2014.11.005","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Harsh Sh, Singh V et al (2015) C-reactive protein, inflammation and coronary heart disease. Egypt Heart J 67(2):89\u201397. https:\/\/doi.org\/10.1016\/j.ehj.2014.11.005","journal-title":"Egypt Heart J"},{"key":"5113_CR18","doi-asserted-by":"publisher","first-page":"41530","DOI":"10.1038\/srep41530","volume":"7","author":"RI Mincu","year":"2017","unstructured":"Mincu RI, J\u00e1nosi RA, Vinereanu D et al (2017) Preprocedural C-reactive protein predicts outcomes after primary percutaneous ioronary intervention in patients with ST-elevation myocardial infarction a systematic meta-analysis. Sci Rep 7:41530. https:\/\/doi.org\/10.1038\/srep41530","journal-title":"Sci Rep"},{"issue":"5","key":"5113_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1055\/s-0038-1650653","volume":"76","author":"J Stouthard","year":"1996","unstructured":"Stouthard J, Levi M, Hack C et al (1996) Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thrombosis Haemost 76(5):738\u2013742","journal-title":"Thrombosis Haemost"},{"issue":"2","key":"5113_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.11909\/j.issn.1671-5411.2017.02.008","volume":"14","author":"J Wang","year":"2017","unstructured":"Wang J, Tan GJ, Han LN, Bai YY et al (2017) Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol 14(2):135\u2013150. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2017.02.008","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"5113_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1157\/13087896","volume":"59","author":"PL S\u00e1nchez","year":"2006","unstructured":"S\u00e1nchez PL, Rodr\u00edguez MV, Villacorta E et al (2006) Cin\u00e9tica de la prote\u00edna C reactiva en las distintas manifestaciones cl\u00ednicas del s\u00edndrome coronario agudo (Kinetics of C-reactive protein release in different forms of acute coronary syndrome). Rev Esp Cardiol 59(5):441\u2013447. https:\/\/doi.org\/10.1157\/13087896","journal-title":"Rev Esp Cardiol"},{"key":"5113_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1365-2249.2000.01281.x","volume":"121","author":"P Skinh\u00f8j","year":"2000","unstructured":"Skinh\u00f8j P, Pedersen AN, Schroll M et al (2000) Ageing, tumour necrosis factor-alpha (TNF-\u03b1) and atherosclerosis. Clin Exp Immunol 121:255\u2013260. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01281.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"5113_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pharmthera.2010.05.002","volume":"127","author":"P Kleinbongard","year":"2010","unstructured":"Kleinbongard P, Heusch G, Schulz R (2010) TNF\u03b1 in atherosclerosis, myocardial ischemia\/reperfusion and heart failure. J Pharmacol Ther 127(3):295\u2013314. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.05.002","journal-title":"J Pharmacol Ther"},{"key":"5113_CR24","first-page":"147","volume":"7","author":"H Baumann","year":"1990","unstructured":"Baumann H, Gauldie J (1990) Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 7:147\u2013159","journal-title":"Mol Biol Med"},{"key":"5113_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/ket333","volume":"53","author":"L Morgan","year":"2014","unstructured":"Morgan L, Emery P, Porter D et al (2014) Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data. Rheumatology 53:186\u2013194. https:\/\/doi.org\/10.1093\/rheumatology\/ket333","journal-title":"Rheumatology"},{"issue":"4","key":"5113_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/acr.20371","volume":"63","author":"C Barnabe","year":"2011","unstructured":"Barnabe C, Martin BJ, Ghali WA (2011) Systematic review and meta-analysis: antitumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res 63(4):522\u2013529. https:\/\/doi.org\/10.1002\/acr.20371","journal-title":"Arthritis Care Res"},{"key":"5113_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF01606532","volume":"423","author":"H Kishikawa","year":"1993","unstructured":"Kishikawa H, Shimokama T, Watanabe T (1993) Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Vichows Arch A Pathol Anat Histopathol 423:433\u2013442. https:\/\/doi.org\/10.1007\/BF01606532","journal-title":"Vichows Arch A Pathol Anat Histopathol"},{"issue":"2","key":"5113_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2265.2006.02448.x","volume":"64","author":"M Karaduman","year":"2006","unstructured":"Karaduman M, Sengul A, Oktenli C et al (2006) Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin Endocrinol 64(2):196\u2013202. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02448.x","journal-title":"Clin Endocrinol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05113-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05113-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05113-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:03:38Z","timestamp":1659499418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05113-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5113"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05113-4","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or non-financial interests that are directly or indirectly related to this work that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the Medical University of Plovdiv (nr KB\u2014752\/2016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The research involved Human Participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"Consent to participate: Every patient\/participant has written consent to participate. Consent for publication: Every patient\/participant has written consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human subjects informed consent"}}]}}